SS Innovations International (NASDAQ: SSII), a developer of surgical robotic technologies, will bring its SSi Mantra surgical robotic system to the Society of Robotic Surgery (SRS) 2026 Annual Meeting, scheduled for July 23-26 in Hollywood, Florida. The company announced that the platform will be demonstrated throughout the conference, with a focal point being a live robotic telesurgery broadcast from India, where a partial nephrectomy will be performed remotely using the SSi Mantra system.
Dr. Sudhir Srivastava, Chairman and CEO of SS Innovations, will participate in multiple conference presentations covering telesurgery, robotic surgery adoption, and regulatory developments. The event provides a platform for the company to highlight its expanding clinical experience and growing focus on remote surgical capabilities, which could have significant implications for healthcare access in underserved regions.
As of July 6, 2026, more than 12,375 procedures have been completed using the SSi Mantra system, including cardiac, pediatric, and telesurgical procedures. Approximately 2,100 physicians have already been trained on the platform, which has been used across more than 170 different surgical procedures. This growing body of clinical evidence suggests the system is gaining traction in the surgical community, potentially positioning it as a competitive alternative to established robotic surgery platforms.
The live telesurgery demonstration is particularly noteworthy as it showcases the system's ability to enable remote surgery, which could reduce geographical barriers to specialized surgical care. For healthcare leaders, this technology may offer a way to extend the reach of expert surgeons to remote hospitals, potentially improving patient outcomes and reducing the need for patient travel. For the broader industry, successful telesurgery demonstrations could accelerate regulatory acceptance and adoption of remote surgical technologies.
SS Innovations’ participation at SRS 2026 also underscores the company’s commitment to engaging with the professional community. The company’s newsroom at https://ibn.fm/SSII provides updates on its latest developments. The full terms of use and disclaimers are available on the InvestorBrandNetwork website at http://IBN.fm/Disclaimer.
This announcement comes at a time when robotic surgery is increasingly being adopted for its precision and minimally invasive benefits. With over 2,100 trained physicians, the SSi Mantra platform is building a user base that could drive further innovation and refinement of the technology. For investors, the clinical milestones and conference presence signal that SS Innovations is actively advancing its commercial strategy, though forward-looking statements caution that actual results may differ due to risks outlined in the company’s SEC filings.
The SRS 2026 Annual Meeting is one of the largest gatherings of robotic surgery specialists, making it a strategic venue for SS Innovations to demonstrate its capabilities and network with potential partners and customers. The live telesurgery, in particular, could capture attention due to its implications for global healthcare delivery. As the company continues to accumulate clinical data and expand its training programs, the impact on the surgical robotics market could be substantial, especially in regions where access to skilled surgeons is limited.
